Accueil   Diary - News   All news Smartox Biotechnology announces research collaboration with Xenon Pharmaceuticals

Smartox Biotechnology announces research collaboration with Xenon Pharmaceuticals

The collaboration combines the expertises of Smartox Biotechnology in the study of animal venoms with Xenon Pharmaceuticals Inc.'s ion channel discovery platform. The VenomScreen® division of Smartox Biotechnology will supply venoms for in vitro screening by Xenon with the aim to identify natural toxins presenting a high selectivity for ion channels of interest.

 

Read the press release